Adma Biologics (ADMA) Goodwill & Intangibles (2017 - 2026)

Adma Biologics (ADMA) has 9 years of Goodwill & Intangibles data on file, last reported at $4.1 million in Q4 2025.

• Quarterly Goodwill & Intangibles rose 3.56% year-over-year to $4.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.1 million (up 3.56% YoY) and the FY2025 annual result came in at $4.1 million, up 3.56% from the prior year.
• Goodwill & Intangibles advanced to $4.1 million in Q4 2025, from $4.0 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $9.6 million in Q1 2021 to a low of $3.9 million in Q1 2024.
• A 5-year average of $5.5 million and a median of $4.3 million in 2023 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2024 — Goodwill & Intangibles surged 115.81% — and 2025, when it tumbled 55.41%.
• Tracing ADMA's Goodwill & Intangibles over 5 years: stood at $5.3 million in 2021, then decreased by 14.17% to $4.5 million in 2022, then retreated by 10.72% to $4.0 million in 2023, then decreased by 0.97% to $4.0 million in 2024, then advanced by 3.56% to $4.1 million in 2025.
• The last three Goodwill & Intangibles figures came in at $4.1 million (Q4 2025), $4.0 million (Q3 2025), and $4.0 million (Q2 2025), per Business Quant data.